One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Evolent Health Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Evolent Health Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Evolent Health Inc’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Evolent Health Inc (EVH)

Before we jump into Evolent Health Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Evolent Health, Inc. is a health care company that delivers clinical and administrative solutions to payers and providers. The Company supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The Company operates through two segments: Evolent Health Services and Clinical Solutions. Its Evolent Health Services segment houses its administrative simplification solution and certain supporting population health infrastructure. Its Clinical Solutions segment includes its specialty management and physician-oriented total cost of care solutions, along with the New Century Health and Evolent Care Partners brands. It offers solutions such as care management, specialty care management, and administrative simplification. Its New Century Health is a national population health provider in managing specialty care for medicare, commercial and medicaid members.

Want to learn more about Evolent Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Evolent Health Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Evolent Health Inc’s Stock Price as of Market Close

As of February 24, 2023, 4:00 PM CST, Evolent Health Inc’s stock price was $34.91.

Evolent Health Inc is down 0.03% from its previous closing price of $34.92.

During the last market session, Evolent Health Inc’s stock traded between $33.30 and $35.80. Currently, there are 95.29 million shares of Evolent Health Inc stock available for purchase.

Unfortunately, Evolent Health Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Evolent Health Inc Stock Price History

Evolent Health Inc’s (EVH) price is currently up 8.35% so far this month.

During the month of February, Evolent Health Inc’s stock price has reached a high of $35.80 and a low of $30.45.

Over the last year, Evolent Health Inc has hit prices as high as $39.78 and as low as $21.83. Year to date, Evolent Health Inc’s stock is up 26.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Evolent Health Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 23, 2023, there were 0 analysts who downgraded Evolent Health Inc’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Evolent Health Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Evolent Health Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Evolent Health Inc (EVH) by visiting AAII Stock Evaluator.

Relative Price Strength of Evolent Health Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of February 23, 2023, Evolent Health Inc has a weighted four-quarter relative price strength of 18.83%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how Evolent Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Evolent Health Inc Stock Price: Bottom Line

As of February 24, 2023, Evolent Health Inc’s stock price is $34.91, which is down 0.03% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Evolent Health Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.